Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHP BENEFIX RECOMBINANT FACTOR IX PRICED AT 8 [cents]/UNIT PREMIUM TO PLASMA-DERIVED PRODUCT; GENETICS INSTITUTE SHIPS FEB. 12; LABEL SPECIFIES DOSE ADJUSTMENT

Executive Summary

Genetics Institute is selling BeneFix recombinant human factor IX at an average wholesale price of $1.18 per unit, an eight cent per unit premium to the plasma-derived factor IX products AlphaNine (Alpha Therapeutic) and Mononine (Centeon). BeneFix is available in single-dose vials of 250, 500 or 1,000 international units.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029708

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel